Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)
Luigi Gargiulo(Humanitas University), Alessandra Narcisi(IRCCS Humanitas Research Hospital), Simone Ribero, Anna Elisabetta Cagni(Azienda Ospedaliera San Gerardo), Francesco Loconsole(University of Bari Aldo Moro), Eugenia Veronica Di Brizzi(University of Campania "Luigi Vanvitelli"), Matteo Megna(University of Padua), Claudio Guarneri(University of Messina), Emanuele Trovato(University of Siena), Valentina Ruffo di Calabria(Azienda Usl Toscana Centro), Leonardo Zichichi(Ospedale Sant Antonio), Claudia Lasagni(University of Modena and Reggio Emilia), Massimo Travaglini(Ospedale A. Perrino), Piergiorgio Malagoli(IRCCS Policlinico San Donato), Fabrizio Amoruso(Azienda Ospedaliera di Cosenza), Pina Brianti(Vita-Salute San Raffaele University), Paolo Dapavo(University of Turin), Marzia Caproni(University of Florence), Aldo Cuccia(Ospedale San Donato), Ruggero Cascio Ingurgio(Humanitas University), Marina Venturini(University of Brescia), Santo Raffaele Mercuri(Vita-Salute San Raffaele University), Valentina Dini(University of Pisa), Antonio Costanzo(Humanitas University), Anna Balato(University of Naples Federico II), Martina Burlando(Ospedale Policlinico San Martino), Mario Valenti(IRCCS Humanitas Research Hospital), Luciano Ibba(Humanitas University), Federico Bardazzi(University of Bologna), Gaetano Licata(Ospedale Sant Antonio), Andrea Carugno(University of Insubria), Francesca Satolli(University of Parma), Alexandra Maria Giovanna Brunasso(Ente Ospedaliero Ospedali Galliera), Francesca Maria Gaiani(IRCCS Policlinico San Donato), Paolo Gisondi(University of Verona), Francesco Caudullo(University of Catania), Maria Letizia Musumeci(University of Catania), Carlo Giovanni Carrera(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Diego Orsini(San Gallicano Hospital), Davide Strippoli(Alessandro Manzoni Hospital), Angelo Valerio Marzano(University of Milan)
Cited by 21
Related Papers
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|377
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
|Dermatology|2020|292
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
|Clinical & Experimental Immunology|2014|239